The Antibody Society

the official website of the antibody society

The Adaptive Immune Receptor Repertoire Community of The Antibody Society

  • LOG IN
  • BECOME A MEMBER
  • About
    • Mission & Activities
    • Board of Directors
    • Our Staff & Volunteers
    • The Antibody Society’s Standing Committees
      • AIRR Community Committee
      • Communication & Membership Committee
      • Executive Committee
      • Finance & Audit Committee
      • Governance & Nominating Committee
      • Initiatives Committee
      • Meetings Committee
    • Sponsors & Partners
  • Society meetings
    • Biopharmaceutical Informatics Symposium
    • Emerging Cancer Therapies Leveraging Gamma-Delta Effector T cells Symposium
    • Emerging Immunotherapeutics for Ovarian Cancer Symposium
    • AIRR Community Meetings
    • Antibody Engineering & Therapeutics (US) 2022
      • 2020 Antibody Engineering & Therapeutics
      • 2019 Antibody Engineering & Therapeutics
      • 2018 Antibody Engineering & Therapeutics
      • What is INN a Name?
        • INN issue updates
    • Antibody Engineering & Therapeutics Europe 2022
    • FOCIS Symposia
  • AIRR Community
    • AIRR-C 2022 Votes
    • AIRR News
    • AIRR Community Service Prize 2022
    • AIRR Publications
    • AIRR Meetings
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-committees
      • Communications Sub-committee
      • Executive Sub-committee
      • Inferred Allele Review Committee
      • Meetings Sub-committee
    • AIRR Data Commons
    • AIRR Community Calendar
    • AIRR Community Webinar Series
    • On AIRR – An AIRR Community Podcast
    • AIRR Community Resources
  • Members only
    • Login
    • Note to members
    • James S. Huston Antibody Science Talent Award
      • 2020 James S. Huston Antibody Science Talent Award Recipient
      • JSH Award Criteria
    • Research Competitions
    • Science Writing Competition
      • Science Writing Competition Winners
    • Discount codes for meeting registration
    • Antibodies in early-stage studies
    • Presentations
  • Upcoming meetings
  • Web Resources
    • Society Publications
    • Antibody News
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies in late-stage clinical studies
    • Research Resources
    • Education Resources
  • Career Center
    • Career Shorts
  • Learning Center
    • Upcoming Webinars
    • Adaptive Immune Receptor Repertoires
    • Antibody Discovery & Development
    • Commercializing Antibody Therapeutics
    • Antibodies to Watch
    • Antibody Validation
  • COVID-19
    • Guide to “Coronavirus in the Crosshairs”
    • COVID-19 Biologics Tracker
    • Meeting Report: The Diagnostic Landscape for COVID-19
You are here: Home / The AIRR Community / AIRR Community Working Groups / Diagnostics Working Group

Diagnostics Working Group

Purpose:

The Diagnostics WG explores the possibility of applying AIRR-seq technology as a diagnostic tool to the clinics. While there has been tremendous progress in the field in terms of understanding the rearrangement of T- and B-cell receptors, binding to antigens, and basic biological function, this understanding has not yet led to larger clinical applicability. The WG wants to find out why this is the case and what the AIRR-C can do to expand AIRR-seq techniques (sequencing and analysis) into the field of diagnostics.

Goals:

  1. Evaluate the usage of AIRR-seq data for diagnostic purposes. These include diagnosis, prognosis, monitoring purposes, inclusion biomarkers for clinical studies, etc.
  2. Identify bottlenecks or challenges for AIRR-seq based clinical assays. These can be software tools, but also data sets or general approaches (statistical, machine learning, pattern recognition, etc).
  3. Collaborate with other AIRR-C WG to brainstorm and promote further development and applications of AIRR-seq clinical testing (e.g. potential project design, standard data collection, software tools, extension to new diseases or uses …).
  4. Represent a link between the AIRR-seq community and regulatory agencies when it comes to using AIRR-seq as a diagnostic tool.
  5. Support the AIRR-C efforts with regard to the sequencing analysis of the immune response against the novel coronavirus SARS-CoV-2.

Plans for 2021 include:

  • Work with other interested WGs on a chapter in Immunogenetics about AIRR sequencing methodology from the standpoint of using them for diagnostics (our part) and help where we can on the other parts
  • Establish a podcast-like interview series with experts in the AIRR sequencing diagnostic space to discuss their work and views
    • Work with Diagnostics WG members, Communications and Meetings SC to help source interviewees and for technical support
    • Work with The Antibody Society for further distribution
      • Potential topics:
        1. Discuss published and future use cases for AIRR sequencing diagnostic testing starting with eg. MRD, COVID-19
        2. Diagnostic methods and study design
        3. Commercial and Research Use Only applications of diagnostic techniques

Members:

Co-leaders: Florian Rubelt, Christopher Gooley, Nicholas Schwab

Members: Rohit Arora, Lmar Babrak, Rachael Bashford-Rogers, Magnolia Bostick, Felix Breden, Syed Ahmad Chan Bukhari, Brian Corrie, Lindsay Cowell, Sol Efroni, Khalil El Mazouari, Christopher Gooley (Co-lead), Victor Greiff, David Klatzmann, Yoshinobu Koguchi, Ton Langerak, Theam Soon  Lim, Eline Luning Prak, Susanna Marquez, Pieter Meysman, Enkelejda Miho, Nima Nouri, Milena Pavlović, Florian Rubelt (Co-lead), Geir Kjetil Sandve, Tilman Schneider-Hohendorf, Nicholas Schwab (Co-lead), Erand Smakaj, Cinque Soto, Ulrik Stervbo, Johannes Trück, Henk-Jan van den Ham, Eric Waltari, and Corey Watson

 

Contact: diagnostics@airrc.antibodysociety.org

 

AIRR Community News

AIRR Community Merchandise Shop Now Open!

April 28, 2022 By Pam Borghardt

The AIRR Communications Sub-committee is pleased to announce the launch of an online merchandise shop featuring AIRR Community logo’d merchandise. Shirts, hoodies, tote bags and stickers are currently available, with additional designs to be added in the future. Be sure to check out the special Immuno-Collection while you are browsing! All products are constructed from certified […]

AIRR Community 2022 Executive Sub-committee Election

April 4, 2022 By Pam Borghardt

With each major meeting interval of the AIRR Community, elections are held for leadership positions on the AIRR-C Executive Sub-committee.  This spring, per our governance, we are seeking nominations for Executive SC Chair-Elect and up to three members of the Executive SC. To nominate an individual to serve on the AIRR-C Executive SC, the nominator […]

AIRR-C WG/SC Calls

All times are in ET (Americas/New York)

Click here for full calendar view

Call - ComRepo
10:00
Thu, May 26, 2022
BioRes WG - Call
10:00
Wed, June 1, 2022
Call - Software
11:30
Wed, June 1, 2022
Call - Legal & Ethics
12:00
Mon, June 13, 2022
Call - Standards
14:00
Mon, June 13, 2022

Recent AIRR Publications

  • Trück J et al, Biological controls for standardization and interpretation of adaptive immune receptor repertoire profiling (eLife, 2021)
  • Arnaout RA, Prak ETL, Schwab N, Rubelt F. Adaptive Immune Receptor Repertoire Community. The Future of Blood Testing Is the Immunome. (Frontiers in Immunology, 2021).

 
See all publications

Archives

Follow Us Online

  • Email
  • LinkedIn
  • Twitter
  • YouTube
  • Slack
  • Home
  • Privacy & Terms of Use
  • About
  • Board of Directors
  • Advisors
  • Sponsors & Partners
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals